MALIGNANT NEOPLASM PROGRESSION

This adverse event was reported 61553 times

These drugs are most commonly taken by patients reporting MALIGNANT NEOPLASM PROGRESSION:

# Drug Count
0 NIVOLUMAB 7046
1 ENZALUTAMIDE 4495
2 PEMBROLIZUMAB 4361
3 EVEROLIMUS 3689
4 CARBOPLATIN 2888
5 DEXAMETHASONE 2696
6 CAPECITABINE 2566
7 IPILIMUMAB 2512
8 LETROZOLE 2224
9 FULVESTRANT 2153
See all common drugs associated with MALIGNANT NEOPLASM PROGRESSION

MALIGNANT NEOPLASM PROGRESSION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AFATINIB 1429 0.2700
1 CERITINIB 364 0.1953
2 GEFITINIB 1448 0.1874
3 RUCAPARIB 1002 0.1570
4 PRALATREXATE 66 0.1560
5 OLAPARIB 1048 0.1527
6 PEMBROLIZUMAB 4361 0.1454
7 RAMUCIRUMAB 541 0.1433
8 OSIMERTINIB 1383 0.1319
9 NIVOLUMAB 7046 0.1284
See all drugs enriched for association with MALIGNANT NEOPLASM PROGRESSION